To significantly boost growth, job creation, and the green and digital transition, it is crucial to unite knowledge, expertise and resources across the EU. The EIT Health’s Flagship “re-industrialisation of Europe” will support the deployment of innovative healthcare products and production processes for pharmaceuticals. It aims to accelerate medical advancement and foster the resilience of the EU health industry by enhancing drug discovery.
As an external contributor to Important Projects of Common European Interest (IPCEI) with a mandate to accelerate and provide complementary support to projects supported by Med4Cure, EIT Health is pleased to announce the launch of the āThe Re-Industrialisation of Europeā Flagship call.
This funding opportunity is designed to provide short term support to the ongoing workstreams and projects of IPCEI Med4Cure, with activities that can lay the groundwork for their long-term success, impact, and sustainability.
More information on EIT Health’s website.